Zobrazeno 1 - 10
of 412
pro vyhledávání: '"TURNER PJ"'
Autor:
Pouessel, G, Deschildre, A, Dribin, TE, Ansotegui, IJ, Cardona, V, Chinthrajah, RS, Ebisawa, M, Muraro, A, Roberts, G, Sampson, HA, Waserman, S, Wood, R, Worm, M, Turner, PJ
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice.
Anaphylaxis reactions lie on a spectrum of severity, ranging from relatively mild lower respiratory involvement (depending on the definition of anaphylaxis used) to more severe reactions which are refractory to initial treatment with epinephrine and
Autor:
Stuart, ASV, Shaw, RH, Liu, X, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Darton, T, Dinesh, T, Duncan, CJA, England, A, Faust, SN, Ferreira, DM, Finn, A, Goodman, AL, Green, CA, Hallis, B, Heath, PT, Hill, H, Horsington, BM, Lambe, T, Lazarus, R, Libri, V, Lillie, PJ, Mujadidi, YF, Payne, R, Plested, EL, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, PJ, Vichos, I, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV2 Study Group
Publikováno v:
Lancet (London, England)
Snape, M D 2022, ' Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial ', Lancet, vol. 399, no. 10319, pp. 36-49 . https://doi.org/10.1016/S0140-6736(21)02718-5
Snape, M D 2022, ' Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial ', Lancet, vol. 399, no. 10319, pp. 36-49 . https://doi.org/10.1016/S0140-6736(21)02718-5
Background Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied mixed priming schedules incorporating an adenoviral-vectored vaccine (ChAdOx1 nCoV-19 [ChAd], AstraZene
Autor:
Arasi, S, Nurmatov, U, Dunn-Galvin, A, Roberts, G, Turner, PJ, Shinder, SB, Gupta, R, Eigenmann, P, Nowak-Wegrzyn, A, Ansotegui, IJ, Rivas, MF, Petrou, S, Tanno, LK, Vazquez-Ortiz, M, Vickery, B, Wong, G, Alvaro-Lozano, M, Asaria, M, Begin, P, Bozzola, M, Boyle, R, Brough, H, Cardona, V, Chinthrajah, RS, Cianferoni, A, Deschildre, A, Fleischer, D, Gazzani, F, Gerdts, J, Giannetti, M, Greenhawt, M, Guzmán, MA, Hossny, E, Kauppi, P, Jones, C, Lucidi, F, Monge Ortega, OP, Munblit, D, Muraro, A, Pajno, G, Podestà, M, Rodriguez del Rio, P, Said, M, Santos, A, Shaker, M, Szajewska, H, Venter, C, Warren, C, Winders, T, Ebisawa, M, Fiocchi, A
Background: While several scoring systems for the severity of anaphylactic reactions have been developed, there is a lack of consensus on definition and categorisation of severity of food allergy disease as a whole. Aim: To develop an international c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907f843fb4faa9e662dfdd6369655f4d
https://hdl.handle.net/11573/1676568
https://hdl.handle.net/11573/1676568
The European Union’s deep-sea fisheries regulations (Regulation (EU) No. 2016/2336) established obligations to manage deep-sea fisheries and to protect vulnerable marine ecosystems (VMEs). The European Commission is scheduled to complete a review o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::eb16dc0c48c92eaf2092c5f9c4f6c1d7
https://zenodo.org/record/5705638
https://zenodo.org/record/5705638
Autor:
Patel, N, Adelman, DC, Anagnostou, K, Baumert, JL, Blom, WM, Campbell, DE, Chinthrajah, RS, Mills, ENC, Javed, B, Purington, N, Remington, BC, Sampson, HA, Smith, AD, Yarham, RAR, Turner, PJ
Publikováno v:
2262.e7
Background Eliciting doses (EDs) (eg, ED01 or ED05 values, which are the amounts of allergen expected to cause objective symptoms in 1% and 5% of the population with an allergy, respectively) are increasingly being used to inform allergen labeling an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::16e2b7565ac7c727ebe6c7bf47f4d071
http://hdl.handle.net/10044/1/87526
http://hdl.handle.net/10044/1/87526
Publikováno v:
Clinical & experimental allergy, vol. 48, no. 5, pp. 502-512, 2018.
IgE-mediated allergic reactions involve the activation of effector cells, predominantly through the high-affinity IgE receptor (FceRI) on mast cells and basophils. Although the mast cell is considered the major effector cell during acute allergic rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::21279076e54cbae6c4f0a950607022ea
https://dirros.openscience.si/IzpisGradiva.php?id=12902
https://dirros.openscience.si/IzpisGradiva.php?id=12902
The North Atlantic is a dynamic space with increasing human uses, the emerging impacts of climate change and numerous policy developments that occur along different timelines at national, regional and global scales. The breadth of expertise within th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7c9439f5001572ccc67aa3cbd18fb6f
Kawasaki disease (KD) is an uncommon condition occasionally reported after childhood vaccination. Admissions with a KD-compatible diagnosis identified from a national database in England were linked to immunisation records to investigate the risk aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::5b21d27c8e88a25c74d7176783f1b8b6
https://researchonline.lshtm.ac.uk/id/eprint/4659429/1/Stowe-etal-2020_The-risk-of-Kawasaki-disease.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4659429/1/Stowe-etal-2020_The-risk-of-Kawasaki-disease.pdf
Publikováno v:
The Journal of Allergy and Clinical Immunology. in Practice
Given the prevalence and impact of childhood food allergy, there is increasing interest in interventions targeting disease prevention. Although interventions such as early introduction of dietary peanut have demonstrated efficacy in a small number of